US Stock MarketDetailed Quotes
LENZ LENZ Therapeutics
- 35.600
- -1.700-4.56%
Close Nov 29 13:00 ET
- 35.600
- 0.0000.00%
Post 13:02 ET
979.03MMarket Cap-8470P/E (TTM)
38.120High35.460Low76.68KVolume37.640Open37.300Pre Close2.77MTurnover0.61%Turnover RatioLossP/E (Static)27.50MShares38.93052wk High4.55P/B445.59MFloat Cap10.03352wk Low--Dividend TTM12.52MShs Float160.912Historical High--Div YieldTTM7.13%Amplitude7.525Historical Low36.096Avg Price1Lot Size
LENZ Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15M | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --15M | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -34.84%12.95M | -4.06%14.35M | 27.52%16.09M | 184.22%72.43M | 173.79%24.99M | 19.87M | 14.96M | 12.62M | 280.68%25.48M | 9.13M |
| Selling and administrative expenses | 126.98%6.49M | 219.27%7.41M | 142.30%5.55M | 196.58%12.93M | 264.26%5.45M | --2.86M | --2.32M | --2.29M | 76.15%4.36M | --1.5M |
| Research and development costs | -62.06%6.45M | -45.05%6.95M | 2.05%10.54M | 181.68%59.5M | 156.04%19.54M | --17M | --12.64M | --10.33M | 400.59%21.13M | --7.63M |
| Operating profit | 34.84%-12.95M | 4.06%-14.35M | -27.52%-16.09M | -590.92%-72.43M | -173.79%-24.99M | -19.87M | -14.96M | -12.62M | -56.60%-10.48M | -9.13M |
| Net non-operating interest income expense | 151.93%2.74M | 881.27%2.46M | 788K | 2.19M | 1.09M | 251K | 0 | |||
| Non-operating interest income | 151.93%2.74M | 881.27%2.46M | --788K | --2.19M | ---- | --1.09M | --251K | --0 | ---- | ---- |
| Other net income (expense) | 94.06%-6K | 9,183.33%1.64M | -2,396.30%-1.35M | 389.47%93K | -107,200.00%-1.07M | -101K | -18K | -54K | 102.19%19K | 1K |
| Other non- operating income (expenses) | 94.06%-6K | 9,183.33%1.64M | -2,396.30%-1.35M | 389.47%93K | -107,200.00%-1.07M | ---101K | ---18K | ---54K | 102.19%19K | --1K |
| Income before tax | 45.90%-10.22M | 30.37%-10.25M | -31.40%-16.65M | -570.37%-70.15M | -161.57%-23.87M | -18.88M | -14.73M | -12.67M | -38.36%-10.46M | -9.13M |
| Income tax | -151.59%-179K | -159.08%-179K | 347K | 303K | ||||||
| Net income | 45.90%-10.22M | 30.37%-10.25M | -31.40%-16.65M | -547.19%-69.97M | -151.27%-23.69M | -18.88M | -14.73M | -12.67M | -42.95%-10.81M | -9.43M |
| Net income continuous Operations | 45.90%-10.22M | 30.37%-10.25M | -31.40%-16.65M | -547.19%-69.97M | -151.27%-23.69M | ---18.88M | ---14.73M | ---12.67M | -42.95%-10.81M | ---9.43M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 45.90%-10.22M | 30.37%-10.25M | -31.40%-16.65M | -547.19%-69.97M | -151.27%-23.69M | -18.88M | -14.73M | -12.67M | -42.95%-10.81M | -9.43M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 45.90%-10.22M | 30.37%-10.25M | -31.40%-16.65M | -547.19%-69.97M | -151.27%-23.69M | -18.88M | -14.73M | -12.67M | -42.95%-10.81M | -9.43M |
| Basic earnings per share | 48.61%-0.38 | 30.64%-0.4 | -611.39%-3.53 | -547.19%-2.7402 | -151.27%-0.9279 | -0.7394 | -0.5767 | -0.4962 | -42.95%-0.4234 | -0.3693 |
| Diluted earnings per share | 48.61%-0.38 | 30.64%-0.4 | -611.39%-3.53 | -547.19%-2.7402 | -151.27%-0.9279 | -0.7394 | -0.5767 | -0.4962 | -42.95%-0.4234 | -0.3693 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data